Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Evaluation of liver failure in a pediatric transplant recipient of a liver allograft with inherited chromosomally integrated HHV-6B.

Bonnafous P, Phan TL, Himes R, Eldin K, Gautheret-Dejean A, Prusty BK, Agut H, Munoz FM.

J Med Virol. 2020 Feb;92(2):241-250. doi: 10.1002/jmv.25600. Epub 2019 Oct 20.

PMID:
31579937
2.

Complementary use of mass spectrometry and cryo-electron microscopy to assess the maturity of live attenuated dengue vaccine viruses.

Trauchessec M, Lambert O, Bonnafous P, Berard Y, Barriere F, Huillet C, Marco S, Sirohi D, Hedrick V, Kuhn R, Guy B, Ronzon F, Manin C.

Vaccine. 2019 Jun 12;37(27):3580-3587. doi: 10.1016/j.vaccine.2019.05.012. Epub 2019 May 20.

PMID:
31122859
3.

Phenotypic and Functional Differences between Human Herpesvirus 6- and Human Cytomegalovirus-Specific T Cells.

Fastenackels S, Bayard C, Larsen M, Magnier P, Bonnafous P, Seddiki N, Appay V, Gautheret-Dejean A, Sauce D.

J Virol. 2019 Jun 14;93(13). pii: e02321-18. doi: 10.1128/JVI.02321-18. Print 2019 Jul 1.

4.

Need for a better characterization of HHV-6 infections and associated clinical impacts.

Bonnafous P, Marlet J, Gaudy-Graffin C, Gautheret-Dejean A.

Am J Transplant. 2019 Jan;19(1):304-305. doi: 10.1111/ajt.15013. Epub 2018 Aug 1. No abstract available.

5.

Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation.

Bonnafous P, Marlet J, Bouvet D, Salamé E, Tellier AC, Guyetant S, Goudeau A, Agut H, Gautheret-Dejean A, Gaudy-Graffin C.

Am J Transplant. 2018 Jun;18(6):1548-1551. doi: 10.1111/ajt.14657. Epub 2018 Jan 27.

6.

The basic tilted helix bundle domain of the prolyl isomerase FKBP25 is a novel double-stranded RNA binding module.

Dilworth D, Upadhyay SK, Bonnafous P, Edoo AB, Bourbigot S, Pesek-Jardim F, Gudavicius G, Serpa JJ, Petrotchenko EV, Borchers CH, Nelson CJ, Mackereth CD.

Nucleic Acids Res. 2017 Nov 16;45(20):11989-12004. doi: 10.1093/nar/gkx852.

7.

Human Herpesvirus 6 (HHV-6) necrotizing encephalitis, a rare condition in immunocompromised patients: The importance of brain biopsy associated with HHV-6 testing.

Le Guennec L, Mokhtari K, Chauvet D, Dupuis N, Roos-Weil D, Agut H, Leclercq D, Psimaras D, Mayaux J, Demeret S, Choquet S, Auvin S, Bonnafous P, Gautheret-Dejean A, Weiss N.

J Neurol Sci. 2017 Jun 15;377:112-115. doi: 10.1016/j.jns.2017.04.003. Epub 2017 Apr 6. No abstract available.

PMID:
28477677
8.

Vaginal Neoplasia Induced by an Unusual Papillomavirus Subtype in a Woman with Inherited Chromosomally Integrated Human Herpesvirus Type 6A.

Pichon M, Gaymard A, Lebail-Carval K, Frobert E, Beaufils E, Chene G, Tommasino M, Lina B, Gaucherand P, Gautheret-Dejean A, Bonnafous P, Gheit T, Buenerd A, Lamblin G, Mekki Y.

Gynecol Obstet Invest. 2017;82(3):307-310. doi: 10.1159/000470907. Epub 2017 Apr 6.

PMID:
28380476
9.

Où en est la recherche sur les antiviraux ?

Agut H, Burrel S, Bonnafous P, Boutolleau D.

Rev Prat. 2016 Nov;66(9):1007-1014. French.

PMID:
30512372
10.

Update on infections with human herpesviruses 6A, 6B, and 7.

Agut H, Bonnafous P, Gautheret-Dejean A.

Med Mal Infect. 2017 Mar;47(2):83-91. doi: 10.1016/j.medmal.2016.09.004. Epub 2016 Oct 20. Review.

PMID:
27773488
11.

Human Herpesviruses 6A, 6B, and 7.

Agut H, Bonnafous P, Gautheret-Dejean A.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.DMIH2-0007-2015. Review.

PMID:
27337451
12.

[Diagnosis and practice of virological monitoring of infections by the human herpesviruses 6A and 6B].

Gautheret-Dejean A, Bonnafous P, Agut H.

Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):156-67. doi: 10.1684/abc.2016.1122. Review. French.

13.

Morphology and Molecular Composition of Purified Bovine Viral Diarrhea Virus Envelope.

Callens N, Brügger B, Bonnafous P, Drobecq H, Gerl MJ, Krey T, Roman-Sosa G, Rümenapf T, Lambert O, Dubuisson J, Rouillé Y.

PLoS Pathog. 2016 Mar 3;12(3):e1005476. doi: 10.1371/journal.ppat.1005476. eCollection 2016 Mar.

14.

HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.

Quintela A, Escuret V, Roux S, Bonnafous P, Gilis L, Barraco F, Labussière-Wallet H, Duscastelle-Leprêtre S, Nicolini FE, Thomas X, Chidiac C, Ferry T, Frobert E, Morisset S, Poitevin-Later F, Monneret G, Michallet M, Ader F; Lyon HEMINF Study Group.

J Infect. 2016 Feb;72(2):214-22. doi: 10.1016/j.jinf.2015.09.039. Epub 2015 Oct 28.

PMID:
26518057
15.

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.

Calland N, Sahuc ME, Belouzard S, Pène V, Bonnafous P, Mesalam AA, Deloison G, Descamps V, Sahpaz S, Wychowski C, Lambert O, Brodin P, Duverlie G, Meuleman P, Rosenberg AR, Dubuisson J, Rouillé Y, Séron K.

J Virol. 2015 Oct;89(19):10053-63. doi: 10.1128/JVI.01473-15. Epub 2015 Jul 22.

16.

Laboratory and clinical aspects of human herpesvirus 6 infections.

Agut H, Bonnafous P, Gautheret-Dejean A.

Clin Microbiol Rev. 2015 Apr;28(2):313-35. doi: 10.1128/CMR.00122-14. Review.

17.

Impact of HIV-1 infection on herpes simplex virus type 2 genetic variability among co-infected individuals.

Abrão EP, Burrel S, Désiré N, Bonnafous P, Godet A, Caumes E, Agut H, Boutolleau D.

J Med Virol. 2015 Mar;87(3):357-65. doi: 10.1002/jmv.24061. Epub 2014 Sep 1.

PMID:
25174847
18.

Presence of HHV-6 genome in spermatozoa in a context of couples with low fertility: what type of infection?

Godet AN, Soignon G, Koubi H, Bonnafous P, Agut H, Poirot C, Gautheret-Dejean A.

Andrologia. 2015 Jun;47(5):531-5. doi: 10.1111/and.12299. Epub 2014 May 20.

PMID:
24846813
19.

Treatment of influenza virus with beta-propiolactone alters viral membrane fusion.

Bonnafous P, Nicolaï MC, Taveau JC, Chevalier M, Barrière F, Medina J, Le Bihan O, Adam O, Ronzon F, Lambert O.

Biochim Biophys Acta. 2014 Jan;1838(1 Pt B):355-63. doi: 10.1016/j.bbamem.2013.09.021. Epub 2013 Oct 16.

20.

Hepatitis B subvirus particles display both a fluid bilayer membrane and a strong resistance to freeze drying: a study by solid-state NMR, light scattering, and cryo-electron microscopy/tomography.

Grélard A, Guichard P, Bonnafous P, Marco S, Lambert O, Manin C, Ronzon F, Dufourc EJ.

FASEB J. 2013 Oct;27(10):4316-26. doi: 10.1096/fj.13-232843. Epub 2013 Jul 9.

PMID:
23839934
21.

The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: toward an understanding of its selectivity for cancer cells.

Jobin ML, Bonnafous P, Temsamani H, Dole F, Grélard A, Dufourc EJ, Alves ID.

Biochim Biophys Acta. 2013 Jun;1828(6):1457-70. doi: 10.1016/j.bbamem.2013.02.008. Epub 2013 Feb 24.

22.

HDP-CDV as an alternative for treatment of human herpesvirus-6 infections.

Bonnafous P, Bogaert S, Godet AN, Agut H.

J Clin Virol. 2013 Feb;56(2):175-6. doi: 10.1016/j.jcv.2012.11.006. Epub 2012 Nov 21. No abstract available.

PMID:
23177166
23.

Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.

Burrel S, Bonnafous P, Hubacek P, Agut H, Boutolleau D.

Antiviral Res. 2012 Dec;96(3):386-90. doi: 10.1016/j.antiviral.2012.09.016. Epub 2012 Oct 3.

PMID:
23041200
24.

A yeast toxic mutant of HET-s amyloid disrupts membrane integrity.

Ta HP, Berthelot K, Coulary-Salin B, Castano S, Desbat B, Bonnafous P, Lambert O, Alves I, Cullin C, Lecomte S.

Biochim Biophys Acta. 2012 Sep;1818(9):2325-34. doi: 10.1016/j.bbamem.2012.04.013. Epub 2012 Apr 27.

25.

Quantitation of human herpesvirus-6A, -6B and -7 DNAs in whole blood, mononuclear and polymorphonuclear cell fractions from healthy blood donors.

Géraudie B, Charrier M, Bonnafous P, Heurté D, Desmonet M, Bartoletti MA, Penasse C, Agut H, Gautheret-Dejean A.

J Clin Virol. 2012 Feb;53(2):151-5. doi: 10.1016/j.jcv.2011.10.017. Epub 2011 Nov 30.

PMID:
22133730
26.

Morphological characterization and fusion properties of triglyceride-rich lipoproteins obtained from cells transduced with hepatitis C virus glycoproteins.

Pécheur EI, Diaz O, Molle J, Icard V, Bonnafous P, Lambert O, André P.

J Biol Chem. 2010 Aug 13;285(33):25802-11. doi: 10.1074/jbc.M110.131664. Epub 2010 Jun 15.

27.

Activity of H2G on human herpesvirus-6B strains either sensitive or resistant to ganciclovir.

Bonnafous P, Agut H.

J Clin Virol. 2010 Jun;48(2):153-4. doi: 10.1016/j.jcv.2010.03.019. Epub 2010 Apr 14. No abstract available.

PMID:
20395169
28.

Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads.

Bonnafous P, Perrault M, Le Bihan O, Bartosch B, Lavillette D, Penin F, Lambert O, Pécheur EI.

J Gen Virol. 2010 Aug;91(Pt 8):1919-1930. doi: 10.1099/vir.0.021071-0. Epub 2010 Apr 7.

PMID:
20375221
29.

Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development.

Bonnafous P, Verbelen M, Petrella S, Deback C, Gautheret-Dejean A, Boutolleau D, Naesens L, Agut H.

Antiviral Res. 2010 Jun;86(3):316-9. doi: 10.1016/j.antiviral.2010.03.005. Epub 2010 Mar 16.

PMID:
20298721
30.

Testing the susceptibility of human herpesviruses to antivirals.

Agut H, Boutolleau D, Deback C, Bonnafous P, Gautheret-Dejean A.

Future Microbiol. 2009 Nov;4(9):1111-23. doi: 10.2217/fmb.09.83. Review.

PMID:
19895215
31.

Cryo-electron tomography of nanoparticle transmigration into liposome.

Le Bihan O, Bonnafous P, Marak L, Bickel T, Trépout S, Mornet S, De Haas F, Talbot H, Taveau JC, Lambert O.

J Struct Biol. 2009 Dec;168(3):419-25. doi: 10.1016/j.jsb.2009.07.006. Epub 2009 Jul 23.

PMID:
19596070
32.

Different expression of human herpesvirus-6 (HHV-6) load in whole blood may have a significant impact on the diagnosis of active infection.

Gautheret-Dejean A, Henquell C, Mousnier F, Boutolleau D, Bonnafous P, Dhédin N, Settegrana C, Agut H.

J Clin Virol. 2009 Sep;46(1):33-6. doi: 10.1016/j.jcv.2009.05.020. Epub 2009 Jun 7.

PMID:
19505844
33.

Length variability of telomeric repeat sequences of human herpesvirus 6 DNA.

Achour A, Malet I, Deback C, Bonnafous P, Boutolleau D, Gautheret-Dejean A, Agut H.

J Virol Methods. 2009 Jul;159(1):127-30. doi: 10.1016/j.jviromet.2009.03.002. Epub 2009 Mar 14.

PMID:
19442857
34.

Farm diversity, classification schemes and multifunctionality.

van der Ploeg JD, Laurent C, Blondeau F, Bonnafous P.

J Environ Manage. 2009 May;90 Suppl 2:S124-31. doi: 10.1016/j.jenvman.2008.11.022. Epub 2009 Jan 9.

PMID:
19135775
35.

Utilization of microsatellite polymorphism for differentiating herpes simplex virus type 1 strains.

Deback C, Boutolleau D, Depienne C, Luyt CE, Bonnafous P, Gautheret-Dejean A, Garrigue I, Agut H.

J Clin Microbiol. 2009 Mar;47(3):533-40. doi: 10.1128/JCM.01565-08. Epub 2008 Dec 24.

36.

Variability of gB and gH genes of human herpesvirus-6 among clinical specimens.

Achour A, Malet I, Le Gal F, Dehée A, Gautheret-Dejean A, Bonnafous P, Agut H.

J Med Virol. 2008 Jul;80(7):1211-21. doi: 10.1002/jmv.21205.

PMID:
18461623
37.

Characterization of a cidofovir-resistant HHV-6 mutant obtained by in vitro selection.

Bonnafous P, Boutolleau D, Naesens L, Deback C, Gautheret-Dejean A, Agut H.

Antiviral Res. 2008 Mar;77(3):237-40. doi: 10.1016/j.antiviral.2007.12.004. Epub 2008 Jan 7.

PMID:
18241936
38.

Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.

Bonnafous P, Naesens L, Petrella S, Gautheret-Dejean A, Boutolleau D, Sougakoff W, Agut H.

Antivir Ther. 2007;12(6):877-88.

PMID:
17926642
39.

Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts.

Naesens L, Bonnafous P, Agut H, De Clercq E.

J Clin Virol. 2006 Dec;37 Suppl 1:S69-75.

PMID:
17276373
40.

Polymorphonuclear leukocytes mainly contribute to human herpesvirus-6 load in the peripheral blood of patients.

Palleau S, Boutolleau D, Bonnafous P, Agut H, Gautheret-Dejean A.

Clin Infect Dis. 2006 May 1;42(9):1342-3. No abstract available.

PMID:
16586395
41.

Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.

Thi TN, Deback C, Malet I, Bonnafous P, Ait-Arkoub Z, Agut H.

Antiviral Res. 2006 Mar;69(3):152-7. Epub 2005 Dec 19.

PMID:
16388859
42.

Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology.

Boutolleau D, Duros C, Bonnafous P, Caïola D, Karras A, Castro ND, Ouachée M, Narcy P, Gueudin M, Agut H, Gautheret-Dejean A.

J Clin Virol. 2006 Mar;35(3):257-63. Epub 2005 Sep 23.

PMID:
16183328
43.

Persistence of DNA in cell cultures may jeopardize the analysis of human herpesvirus 6 dynamics by means of real-time PCR.

Bonnafous P, Gautheret-Dejean A, Boutolleau D, Caïola D, Agut H.

J Virol Methods. 2005 Apr;125(1):95-8. Epub 2005 Jan 28.

PMID:
15737421
44.

Pore formation in target liposomes by viral fusion proteins.

Bonnafous P, Stegmann T.

Methods Enzymol. 2003;372:408-18. No abstract available.

PMID:
14610827
45.

Real-time PCR as a versatile tool for investigating the susceptibility of human herpesvirus 6 to antiviral agents.

Macé M, Manichanh C, Bonnafous P, Précigout S, Boutolleau D, Gautheret-Dejean A, Agut H.

Antimicrob Agents Chemother. 2003 Sep;47(9):3021-4.

46.

Recent advances in amino acid analysis by capillary electrophoresis.

Prata C, Bonnafous P, Fraysse N, Treilhou M, Poinsot V, Couderc F.

Electrophoresis. 2001 Nov;22(19):4129-38. Review.

PMID:
11824633
47.

Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.

Cambau E, Bonnafous P, Perani E, Sougakoff W, Ji B, Jarlier V.

Clin Infect Dis. 2002 Jan 1;34(1):39-45. Epub 2001 Nov 21.

PMID:
11731943
48.

Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.

Consigny S, Bentoucha A, Bonnafous P, Grosset J, Ji B.

Antimicrob Agents Chemother. 2000 Oct;44(10):2919-21.

49.

Activities of several antimicrobials against Mycobacterium ulcerans infection in mice.

Dega H, Robert J, Bonnafous P, Jarlier V, Grosset J.

Antimicrob Agents Chemother. 2000 Sep;44(9):2367-72.

Supplemental Content

Loading ...
Support Center